JW Therapeutics

JW Therapeutics

JW Therapeutics

JW Therapeutics is an independent Chinese immunocell therapy company focus on the Great China cancer market.
Founded
2016
Raised
$280M
Follow us
Alexa global traffic share
Latest funding Show all
Team Size
50+
Employees
Location
Headquarters
Acquisition
FinSMEs

JW Therapeutics Acquires Syracuse Biopharma

$100,000,000 Venture capital (Series B)
ChinaMoneyNetwork , ChinaMoneyNetwork , AVCJ

Chinese Biotech Firm JW Therapeutics Closes $100M Series B Round

ChinaMoneyNetwork

Chinese Cell Therapy Firm JW Therapeutics Closes $90 Million Series A Financing

Health Funding Asia
$90,000,000 Venture capital (Series A)
FinSMEs , AVCJ

JW Therapeutics Raises $90M in Series A Financing

Funding Health